SCHEMBL5283710

SCHEMBL5283710

CC(C)=NN=c1sc2ccccc2n1CCN

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 2/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CNR1 P21554 4/20 0.40
CNR2 P34972 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.39
HIF1A Q16665 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5284148 0.87 CNR1 (0.46) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5284142 0.87 CNR1 (0.46) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5283843 0.87 MAPT (0.45) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5284131 0.85 CNR1 (0.52) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5284128 0.85 CNR1 (0.52) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5282524 0.84 NPSR1 (0.55) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5282522 0.84 NPSR1 (0.55) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5278256 0.83 CNR1 (0.55) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL5278253 0.83 CNR1 (0.55) MAPTNPC1RAB9ASMN1; SMN2HTT
SCHEMBL4615779 0.79 ALDH1A1 (0.51) MAPTNPC1RAB9ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885NPC1 4843/4885RAB9A 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.